These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9244956)

  • 1. [Alendronate-induced esophagitis. A report of 2 cases].
    Girelli CM; Reguzzoni G; Rocca F
    Recenti Prog Med; 1997 May; 88(5):223-5. PubMed ID: 9244956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pill esophagitis.
    Vãlean S; Petrescu M; Cãtinean A; Chira R; Mircea PA
    Rom J Gastroenterol; 2005 Jun; 14(2):159-63. PubMed ID: 15990936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Esophagitis due to alendronate. Report of two cases].
    Tronci S
    Minerva Gastroenterol Dietol; 1998 Sep; 44(3):159-62. PubMed ID: 16495898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alendronate-associated esophageal injury: pathologic and endoscopic features.
    Abraham SC; Cruz-Correa M; Lee LA; Yardley JH; Wu TT
    Mod Pathol; 1999 Dec; 12(12):1152-7. PubMed ID: 10619269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Esophagitis associated with use of alendronate in 5 postmenopausic patients].
    Luciani J; Pigatto V; Naves A; Fay M; Silvestre Begnis M; Piola JC; Prada DB; Pedrana R
    Acta Gastroenterol Latinoam; 2001 May; 31(2):59-63. PubMed ID: 11471319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Alendronate-induced severe esophagitis. A rare and severe reversible side-effect illustrated by three case reports].
    Tóth E; Fork FT; Lindelöw K; Lindström E; Verbaan H; Veress B
    Lakartidningen; 1998 Aug; 95(35):3676-80. PubMed ID: 9748782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Esophagitis associated with alendronate sodium.
    Pizzani E; Valenzuela G
    Va Med Q; 1997; 124(3):181-2. PubMed ID: 9227047
    [No Abstract]   [Full Text] [Related]  

  • 8. The clinical tolerability profile of alendronate.
    Watts N; Freedholm D; Daifotis A
    Int J Clin Pract Suppl; 1999 Apr; 101():51-61. PubMed ID: 12669741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alendronate-induced esophagitis: case report of a recently recognized form of severe esophagitis with esophageal stricture--radiographic features.
    Ryan JM; Kelsey P; Ryan BM; Mueller PR
    Radiology; 1998 Feb; 206(2):389-91. PubMed ID: 9457190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upper gastrointestinal tolerability of alendronate sodium monohydrate 10 mg once daily in postmenopausal women: a 12-week, randomized, double-blind, placebo-controlled, exploratory study.
    Adachi JD; Faraawi RY; O'Mahony MF; Nayar A; Massaad R; Evans JK; Yacik C
    Clin Ther; 2009 Aug; 31(8):1747-53. PubMed ID: 19808133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Drug-induced esophagitis: can stringent indications help prevent this disease picture?].
    Weihrauch TR
    Z Gastroenterol; 1997 Jun; 35(6):525-7. PubMed ID: 9281245
    [No Abstract]   [Full Text] [Related]  

  • 12. A new probable increasing cause of esophageal ulceration: alendronate.
    Colina RE; Smith M; Kikendall JW; Wong RK
    Am J Gastroenterol; 1997 Apr; 92(4):704-6. PubMed ID: 9128331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Esophagitis associated with the use of alendronate.
    de Groen PC; Lubbe DF; Hirsch LJ; Daifotis A; Stephenson W; Freedholm D; Pryor-Tillotson S; Seleznick MJ; Pinkas H; Wang KK
    N Engl J Med; 1996 Oct; 335(14):1016-21. PubMed ID: 8793925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 14 day endoscopy study comparing risedronate and alendronate in postmenopausal women stratified by Helicobacter pylori status.
    Thomson AB; Marshall JK; Hunt RH; Provenza JM; Lanza FL; Royer MG; Li Z; Blank MA;
    J Rheumatol; 2002 Sep; 29(9):1965-74. PubMed ID: 12233894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Avoiding alendronate-related esophageal irritation.
    Lilley LL; Guanci R
    Am J Nurs; 1997 Jul; 97(7):12-4. PubMed ID: 9247373
    [No Abstract]   [Full Text] [Related]  

  • 16. United Kingdom experience with alendronate and oesophageal reactions.
    Mackay FJ; Wilton LV; Pearce GL; Freemantle SN; Mann RD
    Br J Gen Pract; 1998 Apr; 48(429):1161-2. PubMed ID: 9667093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ulcerative esophagitis associated with the use of alendronate sodium: histopathological and endoscopic features].
    Fernandes PA; Pires MS; Gouvêa AP
    Arq Gastroenterol; 2002; 39(3):173-6. PubMed ID: 12778309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pill-induced esophageal injury: endoscopic features and clinical outcomes.
    Abid S; Mumtaz K; Jafri W; Hamid S; Abbas Z; Shah HA; Khan AH
    Endoscopy; 2005 Aug; 37(8):740-4. PubMed ID: 16032493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "Pill esophagitis"--the case of alendronate.
    Castell DO
    N Engl J Med; 1996 Oct; 335(14):1058-9. PubMed ID: 8793934
    [No Abstract]   [Full Text] [Related]  

  • 20. Alendronic acid: new preparation. Limited efficacy, risk of oesophagitis.
    Prescrire Int; 1998 Apr; 7(34):38-40. PubMed ID: 10183379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.